Recent investigation indicated that latent reservoir and immune impairment are responsible for the post-treatment control of HIV infection. In this paper, we simplify the disease model with latent reservoir and immune impairment and perform a series of mathematical analysis. We obtain the basic infection reproductive number R 0 to characterize the viral dynamics. We prove that when R 0 < 1, the uninfected equilibrium of the proposed model is globally asymptotically stable. When R 0 > 1, we obtain two thresholds, the post-treatment immune control threshold and the elite control threshold. The model has bistable behaviors in the interval between the two thresholds. If the proliferation rate of CTLs is less than the post-treatment immune control threshold, the model does not have positive equilibria. In this case, the immune free equilibrium is stable and the system will have virus rebound. On the other hand, when the proliferation rate of CTLs is greater than the elite control threshold, the system has stable positive immune equilibrium and unstable immune free equilibrium. Thus, the system is under elite control.
Introduction 13
In 2010, an HIV-infected mother gave birth to a baby prematurely in a Mississippi 14 clinic. The infant was known as the 'Mississippi baby'. Before delivery, the mother was 15 not diagnosed with HIV infection did not receive antiretroviral treatment [26] . At the 16 age of 30 hours, the baby received liquid, triple-drug antiretroviral treatment. Such 17 treatment was terminated at the age of 18 months and since then, the virus level in the 18 baby remains undetectable. Though it was thought that the baby was cured of HIV, a 19 routine clinical test on July 10, 2014 showed that the level of virus in the 'Mississippi 20 baby' became detectable (16, 750 copies/ml) [26] . 21 Antiretroviral therapy (ART) is effective in inhibiting the HIV infection and 22 prolongs the life of infected individuals. However, due to the existence of latent 23 reservoirs, it is unable to totally eliminate the virus infection [7, 8, 12, 13, 48] . The time 24 it takes the virus to rebound varies. For example, the virus level of the Mississippi baby 25 remains undetectable for years before the virus rebound [26, 30] . Sometimes, a host may 26 have low virus load after antiretroviral therapy. Investigations have been carried out to 27 reveal the causes of low virus level and virus rebound [9, 30, 38] . 28 Conway and Perelson constructed a mathematical model to investigate the dynamics 29 of virus rebound [9] . Their investigation reveals the interplay between immune response 30 and latent reservoir, and shows that post-treatment control may appear. Recent 31 investigations indicated that early antiretroviral therapy may be responsible for the 32 development of post-treatment control with plasma virus remaining undetectable after 33 the cessation of treatment. However, only a small proportion of patients receiving early 34 antiretroviral therapy developed post-treatment control. Further investigations are to be 35 carried out to reveal the reasons behind this. 36 Treasure et al investigated the HIV rebound in patients who terminated the 37 antiretroviral therapy. They showed that a patient who discontinued the antiretroviral 38 therapy may or may not undergo immediate HIV rebound [38] . 39 As an important approach to investigate disease transmission, mathematical 40 modeling provides insights into interactions between viral and host factors. Evaluating 41 the behaviors of the viral models yields a better understanding of the disease and is Regoes et al. [32] incorporated immune impairment into viral models to consider the 48 effects that target cell limitation and immune responses have on the evolution of virus. 49 Their investigations indicated that the immune system of the host may collapse when Rong and Perelson [34] performed a thorough study on the replenishment of the latent 65 reservoir induced by latently infected cells that are occasionally reactivated. The 66 authors indicated that such scenario corresponds to the half-life of the latent reservoir. 67 Post-treatment control of HIV attracted the attention of researchers. Conway and
68
Perelson integrated the post treatment into an HIV model and performed analysis [9] . 69 Here, we simplify the model proposed in [9] to obtain
where x denotes the concentration of activated CD4 + T cells, L latently infected cells, y 71 productively infected CD4 + T cells and z the immune cells. The effectiveness of both 72 drug classes is represented by ∈ [0, 1]. Here is also known as the overall treatment 73 effectiveness of HIV. If the treatment is terminated, = 0. If the therapy is 100% 74 effective, we have = 1 [9, 33] .
75
In the literature, the immune and immune impairment function cyz 1+ηy − bz − myz 76 has been applied to the viral models to characterize the interaction between the immune 77 cells and the productively infected CD4 + T cells [11, 31, 39] . Wang and Liu [39] 78 constructed a within-host viral dynamics models to consider HIV infection with immune 79 impairment. In this article, we consider the post-treatment immune control, the 80 biological implication behind the 'Mississippi baby'. By mathematical analysis, we 81 obtain the threshold of proliferation rate of CTLs, which determines the HIV infection 82 status. We also perform bifurcation analysis and demonstrate the bistable behavior of 83 the model, which is consistence with results from recent medical trial. 84 1 Preparation
85
In this section, we perform mathematical analysis for the model (1.1). We prove the 86 positiveness and boundedness of the solutions to system (1.1) and calculate the 87 equilibria of the model. In the following, we show that system (1.1) is well-posed.
90
Theorem 2.1. System (1.1) has a unique nonnegative solution with initial values
Furthermore, the solution is bounded.
93
Proof. It follows from the fundamental theory of ordinary differential equations [14] 94 that there exists a unique solution to system (1.1) with nonnegative initial conditions.
95
For any nonnegative initial data, let t 1 > 0 be the first time when x(t 1 ) = 0. From 96 the first equation of (1.1) we have thatẋ(t 1 ) = s > 0, which implies that x(t) < 0 for 97 t ∈ (t 1 − ε 1 , t 1 ), where ε 1 is an arbitrarily small positive constant. This is a For case(i), since x(t) is positive, it follows from the variation of constants formula 105 that L(t 2 ) = L(0) + e − t 2 0 (a+d L −ρ)dξ t2 0 α L (1 − )βx(ξ)y(ξ)dξ > 0, which is in 106 contradiction to L(t 2 ) = 0.
107
For case (ii), the third equation of system (1.1) implies that 108 y(t 2 ) = y(0) + e
0 aL(ξ)dξ > 0, which is in contradiction 109 to y(t 2 ) = 0. Thus, L(t) and y(t) are always positive. 110 Next, we expatiate upon the boundedness of solutions of (1.1). Let 111
. Since all solutions of (1.1) are positive, we have 112
Let ϕ denote the solution to the following system
where x 0 , y 0 and z 0 are the initial values of system (1.1) and ϕ 0 = K 0 > 0. We then 114 obtain lim t→+∞ sup ϕ(t) = s r . By comparison theorem [35] , we get K(t) < ϕ(t).
115
Therefore, x(t), L(t), y(t) and z(t) are bounded. 116 
Equilibria

117
In this section, we consider the existence of the equilibria to system (1.1).
118
(i) If R 0 < 1, system (1.1) only has an infection-free equilibrium E 0 = ( s d , 0, 0, 0), where
is the basic infection reproductive number. Here, R 0 is the expected number of newly 119 infected cells generated from an infected cell at the beginning of the infectious process. 120 (ii) If R 0 > 1, system (1.1) also has an immune-free equilibrium 
We then get the existence conditions 122 for the positive equilibria.
(iii) If R * − > 1 and c > c 2 , system (1.1) has an immune equilibrium E * − = (x * − , L * − , y * − , z * − ). If R * + > 1 and c > c 2 , system (1.1) has an immune equilibrium E * + = (x * + , L * + , y * + , z * + ) as well. Here
Denote
We then have the following results.
If c < c * and one of the conditions c < c 1 or c > c 2 holds, then R * − is always greater Table 1 . The existence of the positive equilibria when 1 In this section, we consider the stability of the equilibria of system (1.1).
The characteristic equation of the linearized system of (1.1) atẼ is given by
It is easy to see that equation (3.2) has two negative roots, obtained as
The other eigenvalues are determined by 
Thus, if R 0 ≤ 1, thenV | (1.1) ≤ 0. Since x, L, y, z are positive, we haveV = 0 if and only 172 if (x, L, y, z) = (x 0 , 0, 0, 0). Therefore, it follows from the classical Krasovskii-LaSalle 173 principle [21, 22] that E 0 is globally asymptotically stable.
174
Biologically, the global asymptotic stability of the uninfected equilibrium E 0 of 175 system (1.1) implies that the virus will die out in the host if the treatment is strong 176 enough to ensure R 0 < 1. Proof. The characteristic equation of the linearized system of (1.1) at E 1 is given by
Clearly,
We then consider the sign of the eigenvalue
Let ∆ = 0, we have c = c 1 or c = c 2 .
186
(i) If ∆ = 0, then c = c 1 or c = c 2 , which is a critical situation.
187
(ii) If ∆ < 0, then c 1 < c < c 2 , and we have λ < 0. In this subsection, we consider the stability of the positive equilibria. Here, we use 199 E * = (x * , L * , y * , z * ) to denote a positive equilibrium of system (1.1).
200
Theorem 3.4. Proof. The characteristic equation of the linearized system of (1.1) at an arbitrary 208 positive equilibrium E * is given by
201
. It thus follows that 212
Clearly, A i > 0, i = 1, 2, 3 and
Routh-Hurartz Criterion, we know that the positive equilibrium E * + is a stable node in 215 this case. The stabilities of the equilibria and the behaviors of system (1.1) are summarized in 222 Tables 3 and 4 . Table 3 . The stabilities of the equilibria and the behaviors of system (1.1) in the case 1 < R 0 < R c . Here, c * * is the critical value, and we assume Sensitive analysis provides insights into the basic infection reproductive number R 0 with 226 respect to system parameters [47] . In this section, we use latin hypercube sampling 227 (LHS) and partial rank correlation coefficients (PRCCs) [4, 24] to reveal the dependence 228 of the basic infection reproduction number R 0 on a variety of system parameters. As a 229 statistical sampling method, LHS provides efficient analysis of parameter variations 230 across simultaneous uncertainty ranges in each parameter [4] . PRCC, which is obtained 231 from the rank transformed LHS matrix and output matrix [24] , indicates the 232 parameters that have the most significant influences on the behaviors of the model. In 233 this work, we perform 4000 simulations per run. We use a uniform distribution function 234 to test the PRCCs for a variety of system parameters.
235
The PRCC results of the model, Fig. 1 , illustrate the dependence of R 0 on different 236 system parameters. The estimations of the distributions for R 0 is approximately a 237 normal distribution. We use |PRCC| as an index to test if the parameter has important 238 correlation with the infection reproduction number R 0 . If |PRCC| > 0.4, we say that 239 the correlation is strong. If 0.4 ≥ |PRCC| > 0.2, we say that the correlation is moderate. 240 For 0.2 ≥ |PRCC| > 0, there correlation is weak. As is shown in Fig. 1 , the general rate 241 of CD4 + T cells s, the decay rate of CD4 + T cells d, the infection rate of CD4 + T cells 242 β, the drug efficacy and the latently infected cell death rate d L have significant 243 influence on the infection reproduction number R 0 . In this section, we carry out numerical simulations to consider the HIV dynamics of our 246 model. The parameter values are listed in Table 5 . We then calculate the thresholds 247 R 0 ≈ 3.0030 > 1, R c ≈ 1.4243, c 2 ≈ 0.2914 and c * * ≈ 0.4988. Notice that
.9125 × 10 −011 > 0. We then get the bistable interval 249 (0.2914, 0.4988). In this case, when c < c 2 , the immune-free equilibrium E 1 is stable. bifurcation appear when c passes through 0.2914. The system display bistable behavior 254 for 0.2914 < c < 0.4988. As an example, we simulate the time history of the system for 255 c = 0.45 ∈ (0.2914, 0.4988) with different initial conditions (see Fig. 3 ). We find that, 256 with the same parameter values and different initial conditions, the system may 257 converge to different equilibriums. Such simulation result is consistent with recent clinic 258 trial performed by Treasure et al [38] .
We also consider the influence of system parameters on the elite control threshold 260 c * * by PRCCs. Fig.4 shows that the immune impairment rate of virus m and the 261 proliferation rate of latently infected cells ρ are positively correlated with the elite 262 control threshold c * * . On the other hand, the death rate of infected cells δ has negative 263 correlation with the elite control threshold c * * . It thus follows that decreasing immune 264 impairment rate m is beneficial for obtaining post-treatment immune control. Decrease 265 the immune impairment rate m and the proliferation rate of latently infected cells ρ, and 266 increasing the death rate of infected cells δ are beneficial for the host to get elite control. 267
Discussion
268
In this paper, we investigate the viral dynamics of a simplified within host model. By The proliferation rate of latently infected cells ρ plays an important role in the elite 284 control. It is worth carrying out further investigation to reveal the viral dynamics of the 285 within host model with logistic proliferation rate of latently infected cells, given by 286 system (5.1).
287
Using the same method of analyzing system (1.1), we can get theoretical results.
288
Here, we carry out numerical simulations to show its bistable behaviors. As shown in 289 Fig.5 , if we choose parameters listed in Table 5 and L max = 50, system (5.1) displays 290 bistable behaviors. Table 5 . Table 5 . There are three phases in this figure. In phase I (0 < c < c 2 ), the system has virus rebound. In phase II (c 2 < c < c * * ), the system has bistable behavior. In phase III (c > c * * ), the system is under elite control. Table 5 .
